Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Position in BIIB — Biogen Inc.
CIK 2032331
SINGAPORE, U0
Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,477,418
+$614,668 QoQ
Shares Held
6,838
+45.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#392
of 1,036 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Derivatives in BIIB
reported options exposure · as of Mar 31, 2025CallValue
$875,776
CallShares
6,400
PutValue
$848,408
PutShares
6,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $7,535,126 across 3 Drug Manufacturers - General names. BIIB ranks #3 (19.6% of the industry book) .
All Filings in BIIB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,477,418 | 6,838 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $862,750 | 4,706 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $502,451 | 2,855 | Shares | Defined | 2026-02-11 | |
| 2025-03-31 | $651,768 | 4,763 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $875,776 | 6,400 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $848,408 | 6,200 | Put | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||